WallStreetZenWallStreetZen

NYSE: CLB
Core Laboratories Inc Stock

Overview
ForecastEarningsDividendOwnership
$18.59+0.29 (+1.58%)
Updated Sep 19, 2024
CLB Price
$18.59
Fair Value Price
N/A
Market Cap
$872.11M
52 Week Low
$13.82
52 Week High
$25.20
P/E
35.75x
P/B
3.63x
P/S
1.85x
PEG
0.98x
Dividend Yield
0.22%
Revenue
$513.77M
Earnings
$23.71M
Gross Margin
21%
Operating Margin
10.36%
Profit Margin
4.6%
Debt to Equity
1.47
Operating Cash Flow
$42M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CLB Overview

Core Laboratories N.V. provides core and fluid analysis to the oil and gas industry to increase production from its clients' reservoirs. Specialties include basic rock properties, core analysis, and PVT characterization of reservoir fluids. Analytical and field services characterize the properties of crude oil and integrated diagnostic services evaluate the effectiveness of well completions. Core Laboratories was founded in 1936 and is based in Amstelveen, the Netherlands.

Zen Score

–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLB ($18.59) is trading above its intrinsic value of $10.57, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLB is poor value based on its earnings relative to its share price (35.75x), compared to the US market average (25.52x)
P/E vs Market Valuation
CLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLB due diligence checks available for Premium users.

Be the first to know about important CLB news, forecast changes, insider trades & much more!

CLB News

Valuation

CLB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
35.75x
Industry
12.1x
Market
25.52x
CLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CLB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.63x
Industry
2.4x
CLB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLB price to earnings growth (PEG)

For valuing profitable companies with growth potential
CLB is good value based... subscribe to Premium to read more.
PEG Value Valuation

CLB's financial health

Profit margin

Revenue
$130.6M
Net Income
$9.0M
Profit Margin
6.9%
CLB's Earnings (EBIT) of $53.21M... subscribe to Premium to read more.
Interest Coverage Financials
CLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$597.8M
Liabilities
$352.1M
Debt to equity
1.47
CLB's short-term assets ($233.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLB's long-term liabilities ($254.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$17.1M
Investing
-$687.0k
Financing
-$13.7M
CLB's operating cash flow ($41.89M)... subscribe to Premium to read more.
Debt Coverage Financials

CLB vs Oil & Gas Equipment & Service Stocks

TickerMarket Cap1d %P/EP/B
CLB$872.11M+1.58%35.75x3.63x
PUMP$857.25M+2.36%25.72x0.88x
EFXT$716.81M+4.33%-6.96x0.70x
ACDC$1.04B+1.72%-4.89x0.91x
VTOL$1.04B+3.61%33.42x1.23x
View Top Oil & Gas Equipment & Service Stocks

Core Laboratories Stock FAQ

What is Core Laboratories's quote symbol?

(NYSE: CLB) Core Laboratories trades on the NYSE under the ticker symbol CLB. Core Laboratories stock quotes can also be displayed as NYSE: CLB.

If you're new to stock investing, here's how to buy Core Laboratories stock.

What is the 52 week high and low for Core Laboratories (NYSE: CLB)?

(NYSE: CLB) Core Laboratories's 52-week high was $25.20, and its 52-week low was $13.82. It is currently -26.23% from its 52-week high and 34.52% from its 52-week low.

How much is Core Laboratories stock worth today?

(NYSE: CLB) Core Laboratories currently has 46,912,971 outstanding shares. With Core Laboratories stock trading at $18.59 per share, the total value of Core Laboratories stock (market capitalization) is $872.11M.

Core Laboratories stock was originally listed at a price of $9.03 in Dec 31, 1997. If you had invested in Core Laboratories stock at $9.03, your return over the last 26 years would have been 105.87%, for an annualized return of 2.82% (not including any dividends or dividend reinvestments).

How much is Core Laboratories's stock price per share?

(NYSE: CLB) Core Laboratories stock price per share is $18.59 today (as of Sep 19, 2024).

What is Core Laboratories's Market Cap?

(NYSE: CLB) Core Laboratories's market cap is $872.11M, as of Sep 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Core Laboratories's market cap is calculated by multiplying CLB's current stock price of $18.59 by CLB's total outstanding shares of 46,912,971.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.